Skender Fani - 30 Dec 2022 Form 4 Insider Report for Jupiter Wellness, Inc. (SHOT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Dec 2022, 17:09:23 UTC
Prior SEC filing
01 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Skender Fani

Key filing fact

Skender Fani filed Form 4 for Jupiter Wellness, Inc. (SHOT) on 30 Dec 2022.

Key facts

  • This page summarizes Skender Fani's Form 4 filing for Jupiter Wellness, Inc. (SHOT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Dec 2022, 17:09.

Change

  • Previous filing in this sequence was filed on 01 Nov 2022.
  • Current net transaction value: +$57,654.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JUPW transaction

Common Stock

Purchase

Transaction value
$57,654
Shares
+64,060
Change %
+111%
Price
$0.9000
Shares after
122,000
Date
25 Oct 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JUPW transaction Derivative

Stock options (Right to buy)

Award

Transaction value
$0
Shares
+50,000
Change %
Price
$0.000000
Shares after
50,000
Date
30 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$0.7600
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .